Tenax Therapeutics, Inc.
TENX · NASDAQ
Bulios Fair Price
$2.63
41.4% upside
Trenutna cena
$1.86
Po podatkih Bulios Fair Price je delnica TENX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Tenax Therapeutics, Inc. (TENX) is a pharmaceutical company specializing in the development and commercialization of drugs for cardiovascular diseases and other serious health conditions. With high standards of scientific research and innovative treatment methods, Tenax Therapeutics is a key player in the pharmaceutical industry. Their products have the potential to improve treatment and the quality of life for patients with cardiovascular issues. The company is known for its commitment to scientific excellence and innovations in the field of pharmacy. Tenax Therapeutics, Inc. (TENX) shares could be suitable for investors looking to invest in a sector with high potential for scientific advancement and improved healthcare.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher T. Giordano
Employees
15
Headquarters
Chapel Hill
Prihajajoči dogodki
Earnings
Upcoming earnings report